COPD Trial, Recruiting NCT03263130 Sponsor: Gelb, Arthur F., M.D. Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT03263130
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with both asthma and COPD (a condition sometimes called "asthma-COPD overlap")
  • People who have emphysema (a type of lung damage) and a smoking history of more than 15 pack years (a measure of how much someone has smoked over their lifetime)
  • People who have COPD, chronic bronchitis, or bronchiectasis (a long-term lung condition affecting the airways) with a smoking history of more than 15 pack years

Who may not be able to join:

  • People who have never smoked
  • People who have any other lung or breathing condition not listed above
  • People who have pulmonary fibrosis (scarring of the lungs)
  • People who have another serious illness or condition affecting the body as a whole (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arthur F Gelb, MD, Clin Prof Geffen School of Medicine at UCLA Medical Center

Phone: 562-633-2204

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gelb, Arthur F., M.D.
Registry
ClinicalTrials.gov
Start date
1 January 2017
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Site and Mechanism(s) of Expiratory Airflow Limitation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov